1-3 of 3
Gabriella Magarelli
Close
Sort by
Journal Articles

Dose-Intense Frontline Chemotherapy Changes Molecular Classifier Prognostication in Diffuse Large B-Cell Lymphoma(DLBCL)

Tatyana Feldman, Maher Albitar, Hong Cheng, Kar Chow, Alessandra Petrillo, Ahmetmursel Ulusan, Andrew Ip, Alexandra Della Pia, Gabriella Magarelli, Brittany Lukasik, Lori Leslie, Pritish K. Bhattacharyya, Andrew L. Pecora, Andre H. Goy
Journal: Blood
Blood (2022) 140 (Supplement 1): 11893–11895.
https://doi.org/10.1182/blood-2022-169586
Published: 2022
Journal Articles

COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study

Andrew Ip, MDMSc, Anthony Mato, MD, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, MD, Rosalba Vicioso, BA, Rani Sebti, MD, Cristina Cicogna, MD, Gabriella Magarelli, ACNP-BC, Lori A. Leslie, MD, Andre H. Goy, MD, Tatyana A. Feldman, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-141871
Published: 2020
Journal Articles

A Phase II Study of the Combination of FCR-Lite and Lenalidomide Followed By Lenalidomide Maintenance in Front-Line CLL: The FCR 2 Regimen

Anthony R. Mato, MD MSCE, Kenneth A. Foon, MD, Tatyana Feldman, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Kar Fai Chow, MD, Marisa Valentinetti, BS, Mary Morin, BS, Kelly Azzollini, BS, Gabriella Magarelli, MS, Pritish K. Bhattacharyya, MD, Joshua Zenreich, BS, Christina Howlett, PharmD, BCOP, Lauren-Nicole Pascual, BS, Kara Yanotti, BSN, Sabrina Kdiry, BSN, David Porter, MD, Andre Goy, MD
Journal: Blood
Blood (2014) 124 (21): 4678.
https://doi.org/10.1182/blood.V124.21.4678.4678
Published: 2014